The Commercial Diagnostics Manager for WAINUA will be a strategic and collaborative leader responsible for advancing diagnosis of hATTR-PN at key accounts. They will foster multidisciplinary customer collaboration across IDNs and key physician groups to enable early and accurate diagnosis of hATTR-PN, working collaboratively with internal teams (i.e., Marketing Innovation, IDN team and Medical) on approved patient identification and digital tools. Key customers include non-Treating Diagnostic MD’s, Genetic Counsellors and Non-Treating Multidisciplinary Team involved in testing process (nurse, patient navigators). IDN specialty pharmacy and C-Suite collaboration will be coordinated with Access Strategy and IDN National Account Directors and Clinical Account Directors.
Develop and execute account-specific compliant diagnostic strategies for IDNs/health systems, ACOs and influential physician groups in appropriate matrix collaboration with Sales, Marketing, Medical Affairs, and Market Access teams. Partner with IDN/CAD teams to increase diagnosis. Identify and implement pathways to accelerate screening and diagnosis of hATTR-PN.
Lead high-level discussions with C-suite executives and key decision-makers to educate stakeholders on diagnostic protocols, early patient identification, and high-quality care pathways for hATTR-PN. Build and sustain strategic relationships with key customers including non-treating diagnostic MD’s, genetic counsellors, non-treating multidisciplinary team involved in testing process (nurse, patient navigators), and advocacy groups.
Collaborate with internal and external stakeholders to identify and address system-level barriers to testing and improve patient identification initiatives. Enhance diagnostic expertise to accelerate timely and accurate patient diagnosis, reducing misdiagnosis and minimizing disease impact.
Communicate cross functionally, in real time, to ensure cohesive alignment and execution across key accounts. Drive collaboration with diagnostic and laboratory stakeholders to enhance biomarker testing workflows and access.
Ensure all activities and engagements are approved and adhere to AstraZeneca’s Code of Ethics and regulatory compliance guidelines.
The annual base salary (or hourly rate of compensation) for this position ranges from $160,000-$238,000. However, base pay offered may vary depending on multiple individualized factors, including market location, job-related knowledge, skills, and experience. In addition, our positions offer a short-term incentive bonus opportunity; eligibility to participate in our equity-based long-term incentive program (salaried roles) or to receive a retirement contribution (hourly roles). Benefits offered included a qualified retirement program [401(k) plan]; paid vacation and holidays; paid leaves; and, health benefits including medical, prescription drug, dental, and vision coverage in accordance with the terms and conditions of the applicable plans. Additional details of participation in these benefit plans will be provided if an employee receives an offer of employment. If hired, employee will be in an “at-will position” and the Company reserves the right to modify base salary (as well as any other discretionary payment or compensation program) at any time, including for reasons related to individual performance, Company or individual department/team performance, and market factors.